Feasibility of Patient-Centered Home Care (PCHC) to Reduce Disparities in High-Risk Black Men (BM) with Advanced Prostate Cancer (CaP)

Launched by MAYO CLINIC · Jun 18, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new approach to cancer care called patient-centered home care (PCHC) to see if it can help improve the health and quality of life for Black men with advanced prostate cancer. The goal is to reduce differences in care and outcomes that some patients face. The study is currently recruiting participants who are Black men, aged 18 or older, with a confirmed diagnosis of prostate cancer who need treatment.

To take part in the trial, participants should be willing to fill out questionnaires and join interviews about their experiences with cancer care. They will also have the chance to receive supportive care and therapies at home. This trial aims to understand how home care can better meet the needs of these patients, ultimately helping them manage their condition more effectively.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• * GROUP 1 FOCUS GROUPS:
• • Individuals identifying as Black and male who are familiar with the landscape of medical care and cancer
• GROUP 1 SURVEYS:
• • Are 18 years of age or older
• • Have histologic evidence of prostate adenocarcinoma
• • Are requiring prostate cancer therapy
• • Have an understanding of the protocol and its requirements
• • Are willing to fill in a questionnaire and participate in a focused interview
• • Are able and willing to sign an informed consent
• GROUP 1 INTERVIEWS:
• • Enrollment in the survey phase of the protocol
• GROUP 2:
• • Are 18 years of age or older
• • Have histologic evidence of prostate adenocarcinoma
• • Are requiring active standard hormone-based therapies (degarelix or leuprolide), antibone resorptive agents (zoledronic acid or denosumab), oral anticancer treatments (abiraterone or second-generation androgen receptor blockers) or intravenous chemotherapy (docetaxel)
• • Are receiving part of supportive care/symptom management and/or anti-cancer therapy in the home as part of advanced care at home program (ACH)
• • Have an understanding of the protocol and its requirements
• • Are able and willing to sign an informed consent
• Exclusion Criteria:
• * GROUP 1 FOCUS GROUPS:
• • Individuals who do not identify as Black or male or who have had no extensive interaction with the healthcare system
• GROUP 1 SURVEYS:
• • Do not identify as Black men
• • Have not been diagnosed with advanced/metastatic CaP
• • Are not requiring active standard anti-cancer therapy
• GROUP 1 INTERVIEWS:
• • Not enrolled in the survey phase of the protocol
• GROUP 2:
• • Do not identify as Black men
• • Have not been diagnosed with advanced/metastatic CaP
• • Are not requiring active standard anti-cancer therapy